The quality, result, and prognosis of neurosurgery relies heavily on t
he anaesthetic technique. Many different classes of drugs have been us
ed during neurosurgical anaesthesia. This article reviews the use of i
ntravenous (IV) propofol as an alternative to volatile anaesthetic tec
hniques. Anaesthesia requirements for neurosurgical procedures are ela
borated upon in the first part of the article. The priority of neuroan
aesthesia is to preserve neuronal function by avoiding complications s
uch as hypoxia, hypercarbia, and cardiovascular instability. Thereafte
r, the chosen anaesthetic technique should minimally interfere with ce
rebral autoregulation and CO2 responsiveness, while brain relaxation i
s encouraged by decreasing the cerebral metabolic rate for oxygen (CMR
O(2)) and cerebral blood flow (CBF). In addition, the anaesthetic tech
nique should be associated with rapid and predictable recovery in the
operating theatre in order to allow early evaluation of the surgery. T
he second part of the article describes IV techniques for neurosurgery
as an alternative to volatile anaesthetics, all of which increase CBF
, cerebral blood volume, and intracranial pressure (ICP) in a dose-rel
ated manner and diminish cerebral autoregulation and interfere with ce
rebrovascular CO2 reactivity. Nitrous oxide has a stimulant effect on
cerebral metabolism and is associated with an increase in CBF. On the
other hand, all IV agents except ketamine are associated with decrease
s in CMRO(2) and are cerebral vasoconstrictors. For this reason, it is
rational to use them for the induction and maintenance of anaesthesia
for neurosurgery as part of a total IV anaesthetic technique. The thi
rd part of the article focuses on propofol as the newest representativ
e of IV anaesthetics. It is a sedative-hypnotic agent that has a pharm
acokinetic-dynamic profile ideally suited for continuous infusion. Pro
pofol reduces ICP, CBF, and CMRO(2). Animal models have suggested the
possibility of cerebral protection. The responsiveness of the cerebral
circulation to alterations in arterial blood pressure is maintained.
Evaluating propofol for major neurosurgery demonstrated good quality a
nd depth of anaesthesia, excellent brain relaxation, and minimal surgi
cal bleeding. In conclusion, total IV anaesthesia with propofol has pr
oven to be a valid alternative to conventional thiopentone-isoflurane
anaesthesia for intracranial surgery.